Cumberland Pharmaceuticals CPIX Ifetroban — Non-current inventories
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's ifetroban — non-current inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's ifetroban — non-current inventories?
- Cumberland Pharmaceuticals (CPIX) reported ifetroban — non-current inventories of $40.88K in Q1 2026.
- How has Cumberland Pharmaceuticals's ifetroban — non-current inventories changed year-over-year?
- Cumberland Pharmaceuticals's ifetroban — non-current inventories decreased by 72.8% year-over-year, from $150.4K to $40.88K.
- What does ifetroban — non-current inventories mean?
- This metric represents the value of inventory assets associated with the Ifetroban product line that are not expected to be sold or consumed within the next twelve months. It reflects long-term capital tied up in specialized pharmaceutical materials or products that are held for future development or commercialization phases. Monitoring this balance helps investors assess the company's long-term product pipeline investment and potential obsolescence risks for non-current assets.